• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec9
Federal Pharmaceutical Subsidiary's Two Eye Drops Approved for Market by National Drug Administration
10:02
Federal Pharmaceutical Obtains Approval for Moxifloxacin Hydrochloride Eye Drops
09:59
Nov26
Fed Pharma Zhongshan Branch's Cefoperazone Sodium and Sulbactam Sodium for Injection Passes Consistency Evaluation
09:12
Sep30
Federation Pharma's Innovative Drug UBT37034 Receives Clinical Trial Approval from National Medical Products Administration
08:38
Sep19
Zhongtai Securities Gives 'Buy' Rating to Fed Pharma
06:03
Sep17
CITIC Securities Initiates Coverage of FedPharma with a Strong Buy Rating
06:39

Schedules & Filings

Schedules
Filings
Oct15
Distribution Plan(CST)

Cash dividend 0.175 HKD

Sep26
Distribution Plan(CST)

Cash dividend 0.175 HKD

Sep25
Distribution Plan(CST)

Cash dividend 0.175 HKD

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
06038
0.425
+32.81%
+0.105
08635
0.570
+28.09%
+0.125
08573
0.053
+26.19%
+0.011
03830
0.080
+25.00%
+0.016
01570
6.170
+23.40%
+1.170
02315
35.080
+22.23%
+6.380
01875
2.500
+19.05%
+0.400
00145
0.265
+17.78%
+0.040
02330
0.226
+17.71%
+0.034
00209
0.173
+16.89%
+0.025
View More